257 related articles for article (PubMed ID: 36439094)
1. Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders.
Shi Z; Du Q; Wang X; Wang J; Chen H; Lang Y; Kong L; Luo W; Yang M; Zhou H
Front Immunol; 2022; 13():1027158. PubMed ID: 36439094
[TBL] [Abstract][Full Text] [Related]
2. CD8
Shi Z; Qiu Y; Zhao Z; Wen D; Chen H; Du Q; Zhang Y; Wang J; Yan C; Yang M; Zhou H
Ann Clin Transl Neurol; 2021 Jan; 8(1):43-53. PubMed ID: 33231379
[TBL] [Abstract][Full Text] [Related]
3. Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome.
Boldrini VO; Brito MR; Quintiliano RPS; Scárdua Silva L; Yasuda CL; Cendes F; Farias AS; Damasceno A
Front Neurol; 2023; 14():1208977. PubMed ID: 37662034
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression.
Shi Z; Wang X; Wang J; Chen H; Du Q; Lang Y; Kong L; Luo W; Qiu Y; Zhang Y; Li C; Wen D; Yao J; Cheng X; Cai L; Lin X; Wang R; Mou Z; Li S; Liu D; Zhou H; Zhou H; Yang M
J Neuroinflammation; 2023 Jun; 20(1):138. PubMed ID: 37268957
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament light chain as a biomarker in neuromyelitis optica spectrum disorder: a comprehensive review and integrated analysis with glial fibrillary acidic protein.
Kim S; Lee JJ; Park JS; Kang M; Seok HY
Neurol Sci; 2024 Mar; 45(3):1255-1261. PubMed ID: 38141119
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
[TBL] [Abstract][Full Text] [Related]
7. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
[TBL] [Abstract][Full Text] [Related]
8. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.
Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W
J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578
[TBL] [Abstract][Full Text] [Related]
9. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
10. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
Chang X; Huang W; Wang L; ZhangBao J; Zhou L; Lu C; Wang M; Yu J; Li H; Li Y; Zhao C; Lu J; Quan C
Front Immunol; 2021; 12():647618. PubMed ID: 33796113
[No Abstract] [Full Text] [Related]
11. Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production.
Cotzomi E; Stathopoulos P; Lee CS; Ritchie AM; Soltys JN; Delmotte FR; Oe T; Sng J; Jiang R; Ma AK; Vander Heiden JA; Kleinstein SH; Levy M; Bennett JL; Meffre E; O'Connor KC
Brain; 2019 Jun; 142(6):1598-1615. PubMed ID: 31056665
[TBL] [Abstract][Full Text] [Related]
12. Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder.
Chang H; Cong H; Wang H; Du L; Tian DC; Ma Y; Xu Y; Wang Y; Yin L; Zhang X
Front Immunol; 2021; 12():645277. PubMed ID: 34335563
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
[TBL] [Abstract][Full Text] [Related]
14. Targeting the complement system in neuromyelitis optica spectrum disorder.
Asavapanumas N; Tradtrantip L; Verkman AS
Expert Opin Biol Ther; 2021 Aug; 21(8):1073-1086. PubMed ID: 33513036
[TBL] [Abstract][Full Text] [Related]
15. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes.
Mouchacca P; Chasson L; Frick M; Foray C; Schmitt-Verhulst AM; Boyer C
Immunology; 2015 May; 145(1):24-33. PubMed ID: 25367158
[TBL] [Abstract][Full Text] [Related]
16. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
[TBL] [Abstract][Full Text] [Related]
17. Association of Circulating Follicular Helper T Cells and Serum CXCL13 With Neuromyelitis Optica Spectrum Disorders.
Yang X; Peng J; Huang X; Liu P; Li J; Pan J; Wei Z; Liu J; Chen M; Liu H
Front Immunol; 2021; 12():677190. PubMed ID: 34335576
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder.
Hoshino Y; Noto D; Sano S; Tomizawa Y; Yokoyama K; Hattori N; Miyake S
J Neuroinflammation; 2022 Jan; 19(1):6. PubMed ID: 34991631
[TBL] [Abstract][Full Text] [Related]
19. Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders.
Gao S; Jiao X; Guo R; Song X; Li B; Guo L
Front Immunol; 2024; 15():1357475. PubMed ID: 38576616
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study.
Cai L; Shi Z; Chen H; Du Q; Zhang Y; Zhao Z; Wang J; Lang Y; Kong L; Zhou H
Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
